The experience can vary from person to person
Accessed 05/18/2023, Lederman S, Ottery FD, Cano A, et al
Commonly Reported Side Effects Based on community reports, side effects appear relatively uncommon and typically mild: Most Frequently Reported: Injection site reactions (redness, minor pain, itching) Mild nausea (particularly with oral administration) Temporary dizziness Headache Fatigue Less Commonly Reported: Skin flushing Changes in appetite Temporary mood changes Vivid dreams Theoretical Concerns Growth Factor Effects: BPC-157's upregulation of growth factors raises theoretical concerns for: Cancer promotion in those with existing malignancies Acceleration of undiagnosed tumors Effects on benign growths (polyps, fibroids) No evidence directly supports these concerns, but caution is warranted given the mechanisms involved
Learn more about how to store your Wegovy pens here
Lo que falta: ensayos de seguridad slidos en humanos para Epitalon a travs de rutas comunes y uso a largo plazo
No as of 2024, retatrutide has not been approved by the MHRA or EMA and is currently available only within clinical trials
